Imidazole → HCID 58109239, 화합물

HRID 2037537노트

반응식

HRID 2037537 반응식
CS(O[CH2:6][CH2:7][C@@:8]1([C:31]2[CH:36]=[CH:35][C:34]([F:37])=[CH:33][CH:32]=2)[O:13][C:12](=[O:14])[N:11]([C@H:15]([C:17]2[CH:22]=[CH:21][C:20]([C:23]3[CH:28]=[CH:27][C:26]([F:29])=[CH:25][C:24]=3[F:30])=[CH:19][CH:18]=2)[CH3:16])[CH2:10][CH2:9]1)(=O)=O.[NH:38]1[CH:42]=[CH:41][N:40]=[CH:39]1.C([O-])([O-])=O.[K+].[K+]>C(#N)C>[F:30][C:24]1[CH:25]=[C:26]([F:29])[CH:27]=[CH:28][C:23]=1[C:20]1[CH:21]=[CH:22][C:17]([C@@H:15]([N:11]2[CH2:10][CH2:9][C@@:8]([C:31]3[CH:32]=[CH:33][C:34]([F:37])=[CH:35][CH:36]=3)([CH2:7][CH2:6][N:38]3[CH:42]=[CH:41][N:40]=[CH:39]3)[O:13][C:12]2=[O:14])[CH3:16])=[CH:18][CH:19]=1

참가 물질

5

실험 절차

A mixture of 2-((S)-3-((S)-1-(2′,4′-difluorobiphenyl-4-yl)ethyl)-6-(4-fluorophenyl)-2-oxo-1,3-oxazinan-6-yl)ethyl methanesulfonate (230 mg, 0.43 mmol), imidazole (44 mg, 0.65 mmol), K2CO3 (178.7 mg, 1.29 mmol) in acetonitrile (4 mL) was heated to reflux overnight. The solvent was removed and the residue was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc and the combined organic layer was washed with brine, dried over Na2SO4, filtered and concentrated to give the crude product, which was purified by preparative HPLC to give (R)-3-[(S)-1-(2′,4′-difluoro-biphenyl-4-yl)-ethyl]-6-(4-fluoro-phenyl)-6-(2-imidazol-1-yl-ethyl)-[1,3]oxazinan-2-one (2.5 mg, 1.2%). LC-MS Method 2 tR=2.14, min, m/z=506; 1H NMR (CDCl3): 1.51 (d, 3H), 2.16-2.63 (m, 7H), 2.94 (m, 2H), 3.91 (m, 1H), 4.32 (m, 1H), 5.66 (m, 1H), 6.25 (m, 1H), 6.81-6.90 (m, 2H), 6.94-7.08 (m, 5H), 7.14-7.26 (m, 6H).

후처리

  1. temperaturewas heated
  2. temperatureto reflux overnight
  3. customThe solvent was removed
  4. customthe residue was partitioned between EtOAc and water
  5. extractionThe aqueous layer was extracted with EtOAc
  6. washthe combined organic layer was washed with brine
  7. dry with materialdried over Na2SO4
  8. filtrationfiltered
  9. concentrationconcentrated
  10. customto give the crude product, which
  11. customwas purified by preparative HPLC

출처 및 근거

ORD 기록
ord-bab89b01d6d24903bf81ff5962f4e746
출처 데이터셋
uspto-grants-2013_11
특허 번호
US08575156B2

반응 노트

불러오는 중…